AEMD
Aethlon Medical, Inc.NASDAQHealthcare$2.12+0.47%ClosedMarket Cap: $1.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.26
P/S
0.00
EV/EBITDA
0.45
DCF Value
$27.87
FCF Yield
-106081.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-219.4%
ROA
-143.0%
ROIC
-103.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $0.00 | -Infinity% | $-2.1M | $-2.0M | $-2.45 | — |
| Q2 2026 | $0.00 | -Infinity% | $-1.5M | $-1.5M | $-3.74 | — |
| Q1 2026 | $0.00 | -Infinity% | $-1.8M | $-1.8M | $-8.50 | — |
| Q4 2025 | $0.00 | -Infinity% | $-2.0M | $-6.3M | $-40.10 | — |
| FY 2025 | $0.00 | NaN% | $-9.3M | $-13.4M | $-85.80 | — |
| Q3 2025 | $0.00 | NaN% | $-1.8M | $-1.8M | $-8.60 | — |
| Q2 2025 | $0.00 | NaN% | $-2.9M | $-2.8M | $-13.80 | — |
| Q1 2025 | $0.00 | NaN% | $-2.6M | $-2.6M | $-12.60 | — |
| Q4 2024 | $0.00 | NaN% | $-2.5M | $-2.4M | $-9.20 | — |
| FY 2024 | $0.00 | NaN% | $-12.6M | $-12.2M | $-48.60 | — |
| Q3 2024 | $0.00 | NaN% | $-3.6M | $-3.5M | $-13.80 | — |
| Q2 2024 | $0.00 | NaN% | $-3.2M | $-3.0M | $-12.20 | — |